These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 4396564)

  • 21. [Comparison of spirographic examinations with blood gases examinations and working capacity in patients with chronic bronchitis and emphysema].
    Pudelski J; Oklek K
    Gruzlica; 1971 Aug; 39(8):815-20. PubMed ID: 5097546
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of Miocor in patients with chronic bronchopneumopathies with coronary insufficiency. 3].
    Molino N; Belluardo C; Molino S
    Minerva Cardioangiol; 1970 Mar; 18(3):204-7. PubMed ID: 5443867
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of pulmonary hemodynamics, blood gases, proteins and immunoglobulin levels in clinical and experimental acute respiratory insufficiency].
    Di Maria G
    Poumon Coeur; 1972; 28(6):285-9. PubMed ID: 4659986
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of a respiratory stimulant (S 2620), orally administered, in obstructive bronchopulmonary disease (Statistical study) (author's transl)].
    Neukirch F; Castillon du Perron M; Verdier F; Drutel P; Legrand M; Botto MJ; Lesobre R
    Bull Physiopathol Respir (Nancy); 1974; 10(6):793-800. PubMed ID: 4156914
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic results in chronic obstructive lung diseases].
    Baumann HR
    Schweiz Med Wochenschr; 1969 Nov; 99(48):1730-3. PubMed ID: 4391429
    [No Abstract]   [Full Text] [Related]  

  • 26. Extravascular lung water in cor pulmonale.
    Turino GM; Edelman NH; Senior RM; Richards EC; Fishman AP
    Aspen Emphysema Conf; 1968; 11():139-50. PubMed ID: 5711540
    [No Abstract]   [Full Text] [Related]  

  • 27. Respiratory disturbances in chronic bronchitis.
    Pham QT; Uffholtz H; Schrijen F
    Scand J Respir Dis; 1974; 55(4):209-17. PubMed ID: 4438982
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognosis in chronic obstructive lung disease.
    Earle RH; Burrows B
    Aspen Emphysema Conf; 1967; 10():453-62. PubMed ID: 5610795
    [No Abstract]   [Full Text] [Related]  

  • 29. [Respiratory insufficiency in reference to blood gases].
    Furuya Y
    Iryo; 1971 Jul; 25(7):533-9. PubMed ID: 5285750
    [No Abstract]   [Full Text] [Related]  

  • 30. Physical training in severe chronic obstructive lung disease. I. Clinical course, physical working capacity and ventilation.
    Brundin A
    Scand J Respir Dis; 1974; 55(1):25-36. PubMed ID: 4853635
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of calcium antagonists under outpatient polyclinic conditions in patients with chronic obstructive bronchitis complicated by cor pulmonale].
    Butorov IV; Bodrug NI; Sandigurskiĭ MI
    Probl Tuberk; 1988; (8):35-7. PubMed ID: 3143996
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the therapy of respiratory insufficiency in chronic pulmonary tuberculosis. Use of analeptics in general and specially of remeflin].
    Fossati C
    G Ital Mal Torace; 1967; 21(6):120-9. PubMed ID: 4389536
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of oral almitrine on gas exchange in chronic respiratory insufficiency and hypercapnia].
    Préfaut C
    Rev Fr Mal Respir; 1980; 8(6):587-97. PubMed ID: 6794117
    [No Abstract]   [Full Text] [Related]  

  • 34. The course and prognosis of chronic obstructive pulmonary disease.
    Davis AL; McClement JH
    Aspen Emphysema Conf; 1968; 11():219-34. PubMed ID: 5711547
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of a corticosteroid with prolonged action in the treatment of chronic respiratory insufficiency secondary to "chronic obstructive pulmonary disease"].
    Scatola L
    Minerva Med; 1966 Oct; 57(79):3191-7. PubMed ID: 5926098
    [No Abstract]   [Full Text] [Related]  

  • 36. [Doxapram: a new analeptic in the isolated and associated therapy of cardiorespiratory insufficiency in medical practice].
    Insinna F
    Chir Patol Sper; 1970 Aug; 18(4):266-328. PubMed ID: 4400406
    [No Abstract]   [Full Text] [Related]  

  • 37. [Spirographic studies on the effects of a new respiratory analeptic substance].
    Geisler L
    Arzneimittelforschung; 1965 Jul; 15(7):798-800. PubMed ID: 4379411
    [No Abstract]   [Full Text] [Related]  

  • 38. Response to a respiratory stimulant (doxapram) in severe respiratory failure.
    Riordan JF; Sillett RW; McNicol MW
    Br J Dis Chest; 1974 Jan; 68(1):39-45. PubMed ID: 4819772
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of a central analeptic drug upon generalized paroxysmal discharges in the EEG of epileptic patients].
    Deisenhammer E; Scherrer H
    Arztl Forsch; 1970 Sep; 24(9):272-4. PubMed ID: 4394457
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral administration of the respiratory stimulant ethamivan in patients with pulmonary insufficiency.
    Shimomura S; McHugh BP; Flatow FA; Bell AL
    Am Rev Respir Dis; 1967 Apr; 95(4):576-83. PubMed ID: 4381445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.